Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005815 | microtubule organizing center | 2 | 1 |
GO:0005874 | microtubule | 6 | 1 |
GO:0005881 | cytoplasmic microtubule | 7 | 1 |
GO:0005930 | axoneme | 2 | 1 |
GO:0036064 | ciliary basal body | 3 | 1 |
GO:0097542 | ciliary tip | 2 | 1 |
GO:0099080 | supramolecular complex | 2 | 1 |
GO:0099081 | supramolecular polymer | 3 | 1 |
GO:0099512 | supramolecular fiber | 4 | 1 |
GO:0099513 | polymeric cytoskeletal fiber | 5 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0005929 | cilium | 4 | 2 |
GO:0031514 | motile cilium | 5 | 2 |
GO:0042995 | cell projection | 2 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 2 |
Related structures:
AlphaFold database: A0A451EJ82
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 122 | 124 | PF00675 | 0.626 |
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.267 |
CLV_NRD_NRD_1 | 212 | 214 | PF00675 | 0.292 |
CLV_NRD_NRD_1 | 23 | 25 | PF00675 | 0.579 |
CLV_NRD_NRD_1 | 253 | 255 | PF00675 | 0.288 |
CLV_NRD_NRD_1 | 32 | 34 | PF00675 | 0.487 |
CLV_NRD_NRD_1 | 39 | 41 | PF00675 | 0.322 |
CLV_PCSK_FUR_1 | 21 | 25 | PF00082 | 0.578 |
CLV_PCSK_KEX2_1 | 122 | 124 | PF00082 | 0.626 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.342 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.579 |
CLV_PCSK_KEX2_1 | 252 | 254 | PF00082 | 0.267 |
CLV_PCSK_KEX2_1 | 32 | 34 | PF00082 | 0.487 |
CLV_PCSK_KEX2_1 | 39 | 41 | PF00082 | 0.322 |
DEG_SPOP_SBC_1 | 98 | 102 | PF00917 | 0.605 |
DOC_MAPK_RevD_3 | 238 | 253 | PF00069 | 0.399 |
DOC_PP2B_LxvP_1 | 138 | 141 | PF13499 | 0.503 |
DOC_PP2B_LxvP_1 | 276 | 279 | PF13499 | 0.384 |
DOC_USP7_MATH_1 | 110 | 114 | PF00917 | 0.740 |
DOC_USP7_MATH_1 | 115 | 119 | PF00917 | 0.729 |
DOC_USP7_MATH_1 | 131 | 135 | PF00917 | 0.624 |
DOC_USP7_MATH_1 | 61 | 65 | PF00917 | 0.728 |
DOC_USP7_MATH_1 | 86 | 90 | PF00917 | 0.710 |
DOC_USP7_MATH_1 | 97 | 101 | PF00917 | 0.696 |
DOC_USP7_UBL2_3 | 269 | 273 | PF12436 | 0.345 |
DOC_WW_Pin1_4 | 111 | 116 | PF00397 | 0.747 |
LIG_14-3-3_CanoR_1 | 107 | 115 | PF00244 | 0.601 |
LIG_14-3-3_CanoR_1 | 202 | 207 | PF00244 | 0.399 |
LIG_14-3-3_CanoR_1 | 67 | 75 | PF00244 | 0.578 |
LIG_14-3-3_CanoR_1 | 88 | 93 | PF00244 | 0.584 |
LIG_BRCT_BRCA1_1 | 86 | 90 | PF00533 | 0.580 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.533 |
LIG_FHA_1 | 244 | 250 | PF00498 | 0.267 |
LIG_LIR_Nem_3 | 275 | 280 | PF02991 | 0.542 |
LIG_SH2_NCK_1 | 45 | 49 | PF00017 | 0.497 |
LIG_SH2_SRC | 45 | 48 | PF00017 | 0.604 |
LIG_SH2_STAT3 | 179 | 182 | PF00017 | 0.285 |
LIG_SH2_STAT5 | 179 | 182 | PF00017 | 0.267 |
LIG_SH2_STAT5 | 78 | 81 | PF00017 | 0.588 |
LIG_SH3_3 | 138 | 144 | PF00018 | 0.652 |
LIG_SH3_3 | 165 | 171 | PF00018 | 0.649 |
LIG_SxIP_EBH_1 | 200 | 213 | PF03271 | 0.399 |
LIG_TRAF2_1 | 215 | 218 | PF00917 | 0.267 |
LIG_TRAF2_1 | 255 | 258 | PF00917 | 0.333 |
LIG_WW_3 | 139 | 143 | PF00397 | 0.503 |
MOD_CK1_1 | 108 | 114 | PF00069 | 0.739 |
MOD_CK1_1 | 157 | 163 | PF00069 | 0.735 |
MOD_CK2_1 | 212 | 218 | PF00069 | 0.267 |
MOD_CK2_1 | 88 | 94 | PF00069 | 0.532 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.673 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.677 |
MOD_GlcNHglycan | 149 | 152 | PF01048 | 0.636 |
MOD_GlcNHglycan | 158 | 162 | PF01048 | 0.570 |
MOD_GlcNHglycan | 57 | 60 | PF01048 | 0.709 |
MOD_GlcNHglycan | 63 | 66 | PF01048 | 0.760 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.615 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.763 |
MOD_GSK3_1 | 153 | 160 | PF00069 | 0.665 |
MOD_GSK3_1 | 63 | 70 | PF00069 | 0.692 |
MOD_GSK3_1 | 84 | 91 | PF00069 | 0.577 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.534 |
MOD_N-GLC_1 | 98 | 103 | PF02516 | 0.692 |
MOD_NEK2_1 | 38 | 43 | PF00069 | 0.513 |
MOD_PIKK_1 | 243 | 249 | PF00454 | 0.298 |
MOD_PKA_1 | 212 | 218 | PF00069 | 0.311 |
MOD_PKA_2 | 212 | 218 | PF00069 | 0.399 |
MOD_PKA_2 | 38 | 44 | PF00069 | 0.541 |
MOD_Plk_4 | 202 | 208 | PF00069 | 0.449 |
MOD_Plk_4 | 272 | 278 | PF00069 | 0.473 |
MOD_ProDKin_1 | 111 | 117 | PF00069 | 0.747 |
MOD_SUMO_rev_2 | 215 | 220 | PF00179 | 0.287 |
TRG_ENDOCYTIC_2 | 45 | 48 | PF00928 | 0.490 |
TRG_ER_diArg_1 | 173 | 176 | PF00400 | 0.586 |
TRG_ER_diArg_1 | 21 | 24 | PF00400 | 0.594 |
TRG_ER_diArg_1 | 212 | 214 | PF00400 | 0.379 |
TRG_ER_diArg_1 | 252 | 254 | PF00400 | 0.352 |
TRG_ER_diArg_1 | 38 | 40 | PF00400 | 0.579 |
TRG_Pf-PMV_PEXEL_1 | 178 | 182 | PF00026 | 0.333 |
TRG_Pf-PMV_PEXEL_1 | 224 | 228 | PF00026 | 0.357 |
TRG_Pf-PMV_PEXEL_1 | 254 | 258 | PF00026 | 0.401 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6N2 | Leptomonas seymouri | 55% | 96% |
A0A0S4J2X9 | Bodo saltans | 36% | 100% |
A0A1X0P2S2 | Trypanosomatidae | 40% | 100% |
A0A422NYA8 | Trypanosoma rangeli | 38% | 100% |
A4HRE7 | Leishmania infantum | 99% | 100% |
C9ZXF2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 100% |
E9AC15 | Leishmania major | 93% | 100% |
E9AJB2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 99% |